BrainStorm Cell Therapeutics
BCLI
#10401
Rank
NZ$11.54 M
Marketcap
NZ$1.05
Share price
0.83%
Change (1 day)
-61.32%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total assets

Total assets on the balance sheet as of June 2025 : NZ$4.43 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total assets are NZ$4.43 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BrainStorm Cell Therapeutics - Total assets on balance sheet (from 2002 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$3.24 M-51.18%
2023-12-31NZ$6.65 M-50.01%
2022-12-31NZ$13.31 M-68.95%
2021-12-31NZ$42.86 M-39.66%
2020-12-31NZ$71.04 M632.24%
2019-12-31NZ$9.7 M-42.04%
2018-12-31NZ$16.73 M4.07%
2017-12-31NZ$16.08 M3.49%
2016-12-31NZ$15.54 M-37.72%
2015-12-31NZ$24.95 M97.29%
2014-12-31NZ$12.64 M119.95%
2013-12-31NZ$5.75 M-7.92%
2012-12-31NZ$6.24 M77.64%
2011-12-31NZ$3.51 M149.08%
2010-12-31NZ$1.41 M35.44%
2009-12-31NZ$1.04 M-30.88%
2008-12-31NZ$1.5 M6.64%
2007-12-31NZ$1.41 M37.77%
2006-12-31NZ$1.02 M
2006-03-31NZ$1.42 M14.92%
2005-03-31NZ$1.23 M4984.2%
2004-03-31NZ$0.02 M-70.4%
2003-03-31NZ$0.08 M-43.13%
2002-03-31NZ$0.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
NZ$101.26 B 2,280,998.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$2.48 B 55,884.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$6.28 B 141,531.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$50.52 B 1,138,150.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.40 B 9,015.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA